Fmr LLC Rocket Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 266,049 shares of RCKT stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

266,049

Previous 45,555 484.02%

Holding current value

$1.14 Million

Previous $303,000 114.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.33 - $8.01 $513,751 - $1.77 Million	220,494 Added 484.02%	266,049 $651,000
Q1 2025 May 12, 2025	SELL	$6.67 - $12.72 $560,139 - $1.07 Million	-83,979 Reduced 64.83%	45,555 $303,000
Q4 2024 Feb 13, 2025	SELL	$11.35 - $18.82 $3.81 Million - $6.32 Million	-335,922 Reduced 72.17%	129,534 $1.63 Million
Q3 2024 Nov 13, 2024	SELL	$17.6 - $25.88 $2 Million - $2.95 Million	-113,823 Reduced 19.65%	465,456 $8.6 Million
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $53,963 - $69,792	2,612 Added 0.45%	579,279 $12.5 Million
Q1 2024 May 13, 2024	BUY	$26.16 - $30.74 $1.23 Million - $1.45 Million	47,171 Added 8.91%	576,667 $15.5 Million
Q4 2023 Feb 13, 2024	BUY	$16.78 - $31.94 $3.13 Million - $5.97 Million	186,797 Added 54.51%	529,496 $15.9 Million
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $1.12 Million - $1.79 Million	74,431 Added 27.75%	342,699 $7.02 Million
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $581,263 - $826,873	35,037 Added 15.02%	268,268 $5.33 Million
Q1 2023 May 11, 2023	SELL	$15.79 - $22.6 $409,418 - $585,995	-25,929 Reduced 10.01%	233,231 $4 Million
Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $108 - $159	7 Added 0.0%	259,160 $5.07 Million
Q3 2022 Nov 10, 2022	BUY	$12.37 - $18.41 $402,692 - $599,319	32,554 Added 14.37%	259,153 $4.14 Million
Q2 2022 Aug 12, 2022	SELL	$7.96 - $16.64 $358,717 - $749,881	-45,065 Reduced 16.59%	226,599 $3.12 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $23.68 $2.07 Million - $3.73 Million	-157,460 Reduced 36.69%	271,664 $4.31 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $367,862 - $615,725	-17,094 Reduced 3.83%	429,124 $9.37 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $3.09 Million - $5.51 Million	-112,618 Reduced 20.15%	446,218 $13.3 Million
Q2 2021 Aug 13, 2021	BUY	$39.41 - $47.25 $22 Million - $26.4 Million	558,836 New	558,836 $24.8 Million

Others Institutions Holding RCKT

# of Institutions

222

Shares Held

98.5M

Call Options Held

611K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $323M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account